28363-22-6

Upstream product

• 107-14-2 chloroacetonitrile 
• 95-76-1 m,p-dichloroaniline 
• 151-50-8 potassium cyanide 
• 50-00-0 formaldehyd 
• 7677-24-9 trimethylsilyl cyanide 
• 134919-33-8 (3,4-Dichloro-phenyl)-methoxymethyl-amine 

Downstream Products

• 104856-91-9 2-<(3,4-dichlorophenyl)amino>ethanimidic acid, ethyl ester 
• 104856-93-1 3-<<(3,4-dichlorophenyl)amino>methyl>pyrimido<5,4-e>-1,2,4-triazine-5,7-diamine, hydrate 
• 104856-98-6 N-<(5,7-diaminopyrimido<5,4-e>-1,2,4-triazine-3-yl)methyl>-N-(3,4-dichlorophenyl)formamide 
• 104856-99-7 3-<<(3,4-dichlorophenyl)nitrosoamino>methyl>pyrimido<5,4-e>-1,2,4-triazine-5,7-diamine 
• 104856-92-0 7-amino-N-(3,4-dichlorophenyl)-5-<(phenylmethyl)thio>pyrimido<5,4-e>-1,2,4-triazine-3-methanamine 
• 67084-10-0 2-((3,4-dichloroanilino)methyl)-2-imidazoline hydrochloride 
• 55240-14-7 C₉H₅Cl₃N₂O 
• 65051-17-4 (3,4-Dichloroanilino)-acetic acid 
• 117919-59-2 N-(3,4-dichloro-phenyl)-glycine amide 

Relevant academic research and scientific papers

TiCl4 induced N-methyleneamine equivalents: A new route to aminoacetonitriles

TiCl4 induced N-methyleneamine equivalents from hexahydro-1,3,5-triazines or N-(methoxymethyl)amines were reacted with trimethylsilyl cyanide to give aminoacetonitriles in 40-90% yield.

Method of inhibiting sickling of sickle erythrocytes using substituted-2-imidazolines

Method for inhibiting the sickling of sickle erythrocytes in blood by contacting the sickle erythrocytes with a compound of the formula: STR1 or a pharmaceutically-acceptable salt thereof, wherein X represents sulfur, oxygen or imino; Rm represents chloro, bromo, fluoro or iodo; and Rp represents chloro, bromo, fluoro, iodo, hydroxy, amino or alkyl.